
Enter your email to stay informed about occasional coupons and promotions. We only send emails when there’s something worth sharing.
MOTS-c dosage for metabolic and mitochondrial research has become a key topic in modern peptide science. MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA-c) is a mitochondrial-derived peptide (MDP) that plays a unique role in regulating cellular metabolism and energy balance.
Unlike traditional peptides that act through hormonal pathways, MOTS-c operates at the cellular and mitochondrial level, influencing how cells utilize energy, respond to stress, and regulate metabolic processes.
Because of this distinct mechanism, MOTS-c is widely studied in research areas such as:
In this comprehensive guide, we will explore MOTS-c dosage, mechanism of action, benefits, usage protocols, cycle structures, and safety considerations in research environments.

MOTS-c is a naturally occurring peptide encoded within mitochondrial DNA, making it fundamentally different from most synthetic peptides.
MOTS-c targets metabolic pathways inside cells, particularly those related to energy production and glucose utilization.
Its activation of AMPK (AMP-activated protein kinase) is especially important, as this pathway is often referred to as the body’s “metabolic master switch.”
When discussing MOTS-c dosage for metabolic and mitochondrial research, protocols typically involve intermittent or short-cycle administration.
Followed by a rest period.
MOTS-c is widely studied for its role in improving metabolic efficiency.
Because MOTS-c originates from mitochondria, it plays a direct role in cellular energy production.
Improves how the body processes and uses energy.
Encourages the body to use fat as a fuel source.
Supports glucose uptake and regulation.
Enhances mitochondrial efficiency.
Works independently of endocrine pathways.

| Phase | Duration |
|---|---|
| Initiation | 1 week |
| Active | 3–6 weeks |
| Rest | 2–4 weeks |
MOTS-c is generally considered mild in research settings, but potential effects may include:
MOTS-c is often studied alongside compounds targeting metabolic pathways.
Most research protocols use 5–15 mg per week.
No, it is typically used in intermittent or weekly protocols.
Usually 4–8 weeks, followed by a break.
It is studied for metabolic efficiency and mitochondrial function.
No, it works at the cellular level rather than hormonal pathways.